Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

showed a trendp = 0.0541.1× alpha
The pre-administration baseline AαVal541 level of the AATD patients before they received their first AAT augmentation therapy showed no correlation with baseline pulmonary function, although diffusion capacity (KCO) showed a trend to a negative correlation with baseline AαVal541 level (Spearman’s correlation coefficient—0.624, p = 0.054). 2.4.
showed a trendp = 0.0541.1× alpha
In the following multivariate Cox regression, when the influence of clinical factors such as tumor stage, sex, age, and smoking was excluded, this pathway also showed a trend to be prognostic (HR = 0.315, 95% CI, 0.098–1.018, p = 0.054). 3.6 Mutations in the FA metabolism pathway affect the responsiveness of SCLC cell lines to some drugs Next, we explored the correlation between the frequency of mutations in FA metabolism pathways and the responsiveness of SCLC cell lines to compounds in the GDSC database.
showed a trendp = 0.0541.1× alpha
Regarding complications, there were no significant differences in the occurrence of ≥Grade III Clavien–Dindo complications, while the Comprehensive Complication Index (CCI) showed a trend toward higher values in the older group (mean of 22.9 vs. 16, p = 0.054).
showed a trendP=0.05401.1× alpha
Functional independence An improvement in FIM total score from baseline to month 6 occurred in the ITB arm (+2.68 (10.31)), while a worsening occurred in the CMM arm (−2.58 (11.00)) ( table 3 and figure 3 ); the analysis showed a trend towards a treatment effect in favour of ITB over CMM (P=0.0540).
showed a trendp = .0541.1× alpha
found that the presence of AI-detected ILA showed a trend toward poorer PFS ( p = .054). 30 These findings underscore the necessity for larger-scale studies to elucidate the impact of ILAs on prognosis and clinical outcomes in patients with NSCLC receiving ICIs therapy.
showed a trendP=0.0541.1× alpha
On POD3 patients without EAD showed a trend towards lower Sdc-1 concentration (median POD3 no EAD: 379 ng/mL vs. median POD3 EAD: 734 ng/mL, P=0.054), whereas lower Sdc-1 concentrations were seen in patients without EAD on POD7 (median POD7 no EAD: 288 ng/mL vs. median POD7 EAD: 577 ng/mL, P=0.04) as seen in Figure 1B .